We are at a fundamental inflection point in the history of the pharmaceutical industry where, as a result of the Human Genome Project, we now have the ability to leverage nature’s own information encoding system (the genetic code) to “digitally” encode our drugs so as to target a precise gene that is malfunctioning and neutralize the disease process at its root cause.

As every human disease has genetic drivers, our vision is to dramatically reduce the suffering and death attributable to innumerable diseases across the globe with our first-in-class technology platform.

The therapies we are creating are analogous to heat-seeking missiles in that they are highly specific to only the target gene and promise easy to take and well tolerated medicines.